Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/3/2026

Pharmacokinetic Differences Between Diazepam and Lorazepam

Elimination Half‑Life

  • In adults, diazepam has an elimination half‑life ranging from 20 – 120 hours (average ≈ 51 hours) whereas lorazepam’s half‑life is 8 – 15 hours (average ≈ 12‑16 hours)【1】.
  • In children (2‑12 years), diazepam’s half‑life is 15‑21 hours compared with lorazepam’s 10.5 hours (range 6‑17 hours)【6】.
  • In infants (1 month‑2 years), diazepam’s half‑life is 40‑50 hours versus lorazepam’s 40.2 hours (range 18‑73 hours)【6】.
  • In neonates, diazepam’s half‑life is 50‑95 hours while lorazepam’s is approximately 40 hours【6】.
  • Severe hepatic dysfunction can prolong diazepam’s half‑life up to 500 hours and reduce its clearance by ~50%, whereas lorazepam’s elimination is modestly increased in renal failure【1】【3】【4】.

Active Metabolites

  • Diazepam is metabolized to active compounds (N‑desmethyldiazepam, temazepam, oxazepam) that extend its clinical duration; lorazepam has no active metabolites and is conjugated directly to an inactive glucuronide【1】【2】.
  • N‑desmethyldiazepam, a major active metabolite, has an elimination half‑life of up to 100 hours【3】.
  • These active metabolites can accumulate, especially in patients with renal dysfunction【3】【4】【5】.

Onset of Intravenous Action

  • After a single IV dose, diazepam produces a rapid onset of effect within 2‑5 minutes, whereas lorazepam’s onset is slower, occurring in 15‑20 minutes【1】【2】.

Clinical Implications of Repeated Dosing

  • With extended or repeated dosing, diazepam’s long half‑life and active metabolites lead to significant accumulation and prolonged clinical effects【3】【4】【5】.

Summary Comparative Table

Parameter Diazepam Lorazepam
Elimination Half‑Life 20‑120 hours 8‑15 hours
Active Metabolites Yes (e.g., N‑desmethyldiazepam) None
Onset (IV) 2‑5 minutes 15‑20 minutes

Data derived from the Critical Care Medicine guideline comparative analysis【1】【2】.